Table 6.
Clinical Characteristic | Relative Risk | P |
---|---|---|
CA19-9 increase after surgery | 2.9 | .0002 |
Postoperative CA19-9 > 200 U/mL | 2.7 | .0009 |
T3 v T1/T2 stage | 3.2 | .0008 |
Positive lymph nodes | 2.5 | .001 |
Clinical Characteristic | Relative Risk | P |
---|---|---|
CA19-9 increase after surgery | 2.9 | .0002 |
Postoperative CA19-9 > 200 U/mL | 2.7 | .0009 |
T3 v T1/T2 stage | 3.2 | .0008 |
Positive lymph nodes | 2.5 | .001 |